World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions
Institut Pasteur de Lille · Erasmus MC · +1 more institution
Abstract
To help adapt cardiovascular disease risk prediction approaches to low-income and middle-income countries, WHO has convened an effort to develop, evaluate, and illustrate revised risk models. Here, we report the derivation, validation, and illustration of the revised WHO cardiovascular disease risk prediction charts that have been adapted to the circumstances of 21 global regions.
In this model revision initiative, we derived 10-year risk prediction models for fatal and non-fatal cardiovascular disease (ie, myocardial infarction and stroke) using individual participant data from the Emerging Risk Factors Collaboration. Models included information on age, smoking status, systolic blood pressure, history of diabetes, and total cholesterol. For derivation, we included participants aged 40-80 years without a known baseline history of cardiovascular disease, who were followed up until the first myocardial infarction, fatal coronary heart disease, or stroke event. We recalibrated models using age-specific and sex-specific incidences and risk factor values available from 21 global regions. For external validation, we analysed individual participant data from studies distinct from those used in model derivation. We illustrated models by analysing data on a further 123 743 individuals from surveys in 79 countries collected with the WHO STEPwise Approach to Surveillance.
Citation impact
- FWCI
- 78.87
- Percentile
- 100%
- References
- 60
Authors
101Topics & keywords
- Disease
- Medicine
- Environmental health
- Internal medicine
Funding
- AFAmgen FoundationAward: PG08/008
- AFAetna Foundation
- AHAmerican Heart Association
- ALAbbott Laboratories
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- PPfizerAward: PG08/008
- AAstraZeneca
- GGlaxoSmithKline
- NNovartis
- SSanofi
- MMedtronic
- WHWorld Health Organization
- YUYale University
- TPTeva Pharmaceutical Industries
- PSPortland State University
- UOUniversity of Minnesota
- IYItä-Suomen Yliopisto
- ULUniversité Laval
- JHJohns Hopkins University
- CMCentral Manchester University Hospitals NHS Foundation Trust
- BIBoehringer Ingelheim
- BSBoston Scientific Corporation
- DKDeutsches Krebsforschungszentrum
- NBNHS Blood and Transplant
- RPRegeneron Pharmaceuticals
- WTWellcome TrustAward: 26865
- DZDeutsches Zentrum für Herz-Kreislaufforschung
- KPKowa Pharmaceutical Europe
- ISInternational Society of Hypertension
- SGScottish Government
- UHUniversity Hospitals Bristol NHS Foundation Trust
- MCMedicines Company
- KCKowa Company
- MMylan
- SCShenzhen Center for Health Information
- SSingulex
- NINational Institute for Health and Care ResearchAward: PG08/008
- BHBritish Heart FoundationAwards: RG/18/13/33946, SP/09/002, BHF; SP/09/002, RG/13/13/30194, RE/13/6/30180, PG08/008
- DODepartment of Health and Social Care
- NNNovo Nordisk UK Research Foundation
- UOUniversity of Cambridge
- UCUniversity College London
- UOUniversity of Oxford
- UOUniversity of Glasgow
- DADiabetes Australia
- KHKidney Health Australia
- SASouth African Medical Research Council
- PHPublic Health Agency
- UHUniversität Heidelberg
- ULUniversiteit Leiden
- RGRijksuniversiteit Groningen
- CMCapital Medical University
- CUCambridge University Hospitals
- LULunds Universitet
- UDUniversità degli Studi di Padova
- ISIstituto Superiore di Sanità
- NNNovo Nordisk
- BBiotronik
- LULeids Universitair Medisch Centrum
- HÍHáskóli Íslands
- TUTechnische Universität München
- SBShahid Beheshti University of Medical Sciences
- HUHirosaki University
- MRMedical Research Council CanadaAward: MR/L003120/1
- SServier
- HHjartavernd
- FAFONDATION ALZHEIMER
- NINational Institutes of Health
- JAJohnson and Johnson
- CFCenters for Medicare and Medicaid Services
- UOUniversity of California, San Diego
- PUPfizer UK
- FAFood and Drug Administration
- MSMerck Sharp and Dohme
- IUInstitut universitaire de cardiologie et de pneumologie de Québec, Université Laval
- IMIrving Medical Center, Columbia University
- CSChief Scientist Office, Scottish Government Health and Social Care Directorate
- RPRoche Products
- MRMedical Research CouncilAwards: RG/13/13/30194, MR/L003120/1, MC_UU_12015/1, PG08/008, MR/L003120, MR/L003120/1
- EAEngineering and Physical Sciences Research Council
- EAEconomic and Social Research Council
- EREuropean Research Council
- NHNational Health and Medical Research Council
- HRHealth Research Council of New Zealand
- DSDaiichi Sankyo Company
- RIResearch Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences
- HAHealth and Social Care Research and Development Division
- UBUCLH Biomedical Research Centre
- NCNIHR Cambridge Biomedical Research Centre
- NHNational Heart, Lung, and Blood InstituteAward: PG08/008
- DSDaiichi Sankyo Europe
- CCilag